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CHAPTER I
INTRODUCTION

Heme iron in oxygenated hemoglobin (Hb) can undergo auioxidation

in

erythrocytes since oxygen is a strong oxidant. Autoxidation converts oxygenated Hb
(oxyHb) to oxidized (met) Hb (metHb). In a normal red blood cell (RBC), three percent
of oxyHb is converted to metHb per day (Winterboum, 1985a).

Methemoglobin

reductase converts metHb back to deoxy hemoglobin (deoxyHb) (Chiu et al., 1982).
Superoxide aniort (02·) (Misra and Fridovich, 1972) and hydrogen peroxide (H20 2) are
products of Hb oxidation (Winterboum, 1983; Winterboum, 1985b).

Therefore in

oxidized RBC these oxygen radicals initiate chain reactions as lipid peroxidation and
further protein oxidation (Chiu and Lubin, 1989; Winterboum, 1990a). However, the
generation of radicals during oxidation of Hb and lipid peroxidation in erythrocytes
(Halliwell, 1985) does not necessarily lead to cell death, since a normal RBC is equipped
with an efficient cellular antioxidation system that remove radicals (Chiu et al., 1982).
Extensive oxidation and heme release within the cytosol or adjacent to the membrane
may occur in hemolytic disorders or when red blood cells are under oxidative stress
(Hebbel and Eaton, 1989; Hebbel, 1986).

The heme may cause an increase in

membrane ·rigidity and membrane permeability on erythrocyte membranes.

Our

understanding of Hb toxicity and oxidative stress in erythrocytes under physiological and

2
pathophysiological conditions will depend on our knowledge on individual oxidative
reactions and the exact role of their reaction products generated from Hb oxidation and
lipid peroxidation in erythrocytes. A better understanding of Hb toxicity in the presence
of lipid surface will also further efforts to prepare synthetic blood cell substitutes using
Rb-based oxygen carriers and liposomes (Rudolph, 1988; Bunn, 1993; Tsuchida, 1994;
Alayash and Cashon, 1995).
Despite the fact that the Hb toxicity has been studied for over 100 years and
topics on Hb oxidation and lipid peroxidation in erythrocytes have been well documented
in literature, our understanding of Hb toxicity is still not definitive. Hb toxicity, other
than that related to antigenicity, is generally attributed to oxygen radicals and free iron
generated during Hb oxidation.

Although molecular oxygen itself is oxidative with

respect to superoxide anion radical, hydrogen peroxide, hydroxyl radical and water, its
oxidative potential is normally held in check by kinetic restrictions (Chiu and Lubin,
1989).

Hydrogen peroxide and superoxide production in the presence of hydroxyl

radicals occour very slowly in an aqueous solution.

However, rapid productions_ of

hydroxyl radicals may occur in membrane if ferrous salts are present in membrane,
following a pathway like the Fenton reaction (Fenton, 1894; Haber & Weiss, 1934).
Previous studies show that in the presence of oxygen radicals and H 2O2 , destruction of
heme may occur releasing free iron (scheme I) (Brown and Jones, 1968; Cantoni et al.,
1981). Thus heme iron release and the presence of iron in the aqueous and lipid phases
are important steps in Hb oxidation in erythrocytes.
Hydroxyl radicals may interact with organic substrates such as lipid molecules

3
and efficiently oxidize lipids, especially those with polyunsaturated fatty acids (Stoock

N

A

I

NH

Fe ...._N

I

N

HN

N
~

Fe

~

Scheme 1

and Domandy, 1971), and the implication of lipid peroxidation by hydroxyl radicals has
been extensive (Chiu and Lubinl., 1989; Sevanian and Hochstein,1985; Chiu et al.,
1982).

It is believed that extensive lipid peroxidation in the membrane could lead the

RBC to premature cell death. However, the intrinsic ability of the hydroxyl radical to
'

mediate membrane lipid peroxidation has been questioned. Since hydroxyl radicals are
extraordinarily reactive, they do not survive for more than a few collisions following
their formation, and thus their reactions are intrinsically site specific (Chiu et al., 1982).

It is highly unlikely that these highly reactive intracellular hydroxyl radicals are able to
migrate to the lipid acyl chain region to initiate lipid peroxidation. The hydroxyl radical
is more likely to react with substrates near the site of its generation. However, if heme
or heme iron act as a Fenton reagent in the lipid phase (Kanner and Harel, 1985; Puppo
and Halliwell, 1988 ; Gutteridge et al., 1994), and catalyze the production of hydroxyl
radicals in the lipid phase, this may provide a possible explanation for the ability of
highly reactive hydroxyl radicals to initiate lipid peroxidation (Chiu and Lubinl., 1989).

4

It has also been suggested that a Fe+ 3-dioxygen-Fe+ 2 complex, and not hydroxyl radical,
was the oxidant to initiate lipid peroxidation (Minotti and Aust, 1987). In either model,
the presence of iron in lipid phase is again a critical component for lipid peroxidation.
However, little information is available on the kinetics of free iron released from Hb and
its accumulation in lipid phase.
I used a model Rb-vesicle system with purified Hb in reduced form (oxyHb) and
uniform size lipid vesicles with no initial lipid peroxidation products (LaBrake and Fung,
1992) to study the initial phase of Hb oxidation. This system allows us to specify the
oxidation states of the reactants (Hb and lipid) and reactant concentrations as well as lipid
hydrophobicity.

The system also consists of no exogenous oxidants to complicate

interpretation of experimental results, since different exogenous oxidants may exhibit
different Hb oxidation kinetics and products (van den Berg et al., 1992). I also used
different buffer conditions to study the pH and the ionic strength effects on heme tranfer
into the lipid phase. Thus this model system provides a well-characterized system for
following various intermediate oxidation products in Hb oxidation in the presence of lipid
surface.

It is obviously critical to characterize the intermediates under the same

experimental condition. Yet results of Hb oxidative studies under various conditions,
including different salt concentrations (Marva and Hebbel, 1994), different pH (Sugawara
et al., 1993) and different lipid compositions as well as lipid vesicles with different sizes
(Yang and Huesstis, 1994), were often compared with each other. Sometimes, different
in vivo phenomenon

has been interpreted using results from

non-physiological

conditions (Marva and Hebbel, 1994). Previous studies have shown that lipid surface

5
enhances the initial disappearance of oxyHb (LaBrake and Fung, 1992). I have now
extended the study to include the kinetics of iron accumulation in lipid phase in the Rbsmall unilamellar vesicle (SUV) system.

I also characterized different intermediate

reactions in Rb-lipid systems.
I also used sickle Hb (HbS) for a comparative study with HbA. It has been
reported that HbS has abnormal oxidation properties (Hebbel, 1986).

I found that

oxidative reactions in Rb-SUV . mixture depended on buffer conditions.

The

disappearance of oxyHb was slower in buffers with physiological ionic strength and pH
than in buffers with low ionic strength and low pH, as expected. Under physiological
buffer conditions, extensive iron accumulation in the lipid phase was observed.
Surprisingly, iron concentrations in the aqueous phase, after initial increases, decreased
as a function of time, whereas iron concentrations in the lipid phase continued to
increase. Eventually all iron ions released from Hb were found in the lipid phase. Little
difference was observed between HbA and HbS systems.

CHAPTER II
MATERIALS AND METHODS

2 .1

Materials
An important aspect of these experiments was to have all glassware acid washed

before use. All the buffers were prepared with HPLC grade water, treated with chelex
100 (BioRad, Richmond, CA) and filtered through an 0.2 micron filter (Gelman Science
Ann Arbor, MI) to eliminate trace metal ions and any exogenous oxidants.

Bovine

phosphatidylserine (BPS) was purchased from Avanti Polar Lipids (Albaster, AL). All
other chemicals were purchased from Sigma (St Louis, MO), Fisher (Pittsburgh, PA) or
Aldrich (Milwaukee, WI).

2.2

Buffers
Phosphate (35 mM) or tris (10 mM) based buffers were used. Variation of ionic

strength (osmolarity) was achieved by addition of either NaCl or KCl to buffers. Precise
osmolarity values were measured using a Vapor Pressure 5500 Osmometer (Wercor,
Logan, UT).

The following abbreviations were used to represent different buffer

systems. We designated phosphate buffers with P and tris buffers with T, followed by
salt concentration (mM), then by Nor K for NaCl and KCl salt used respectively and
ended by its pH value. For example, Pl10N7.4 was a phosphate buffer containing 110
6

7

mM NaCl at pH 7.4, and T5K6.5 was a tris buffer containing 5 mM KCl at pH 6.5.
Pll0N7.4 was used in our earlier studies (La.Brake and Fung, 1992) and was a buffer
with ionic strength and pH similar to physiological conditions. T5K6.5 was the buffer
used by others in a study of sickle Hb oxidation in the presence of lipid vesicles (Marva
and Hebbel, 1994) and was a low salt and low pH buffer. Other buffers used include
P10N7.4, P10N6.5, P50N6.5, PON6.5, T85K6.5, T20K6.5, T5K6.5 and T5N6.5.

2.3

Hemolysate Preparation
Packed RBCs (normal RBC or sickle RBC) were washed using 4 volumes of 35

mM phosphate and 150 mM NaCl pH 7.4 buffer (PBS). The washing was performed
by suspending the RBC in the buffer and then centrifuging at 1500 g for 10 min. The
supernatant and the huffy coat was removed by aspiration. This washing was repeated
4 times until the supernatant were clear. The washed RBCs were then lysed by addition
of 2 volumes of cold DI water. A 77% ammonium sulphate solution at pH 7.0 was used
for the precipitation of membrane proteins in the lysed RBCs. This solution was then
centrifuged and the supernatant was obtained. The solution was CO gassed and dialyzed
overnight against 5 mM phosphate pH 7.4 buffer to remove 2,3 -diphosphoglycerate and
other small molecules. The resulting solution was then CO gassed, concentrated and
stored at -70 °C (La.Brake and Fung, 1992).

2.4

Hemoglobin Preparation
Hb (HbA or HbS) was isolated from stripped hemolysate that was previously
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prepared and was stored at-70 °C. The hemolysate was separated on a DEAE-sephadex
A-50 (Pharmacia, Piscataway, NJ) column under a pH gradient made from 5 mM tris
and 150 mM EDTA at pH 8.3 and pH 7.0. HbA was eluted at pH 7.75 and HbS was
eluted at pH 7.9 (Winterbourn, 1985c; La.Brake and Fung, 1992).

The purified

hemoglobin fractions were CO gassed and dialyzed against 35 mM phosphate and 110
mM NaCl pH 7.4 buffer.

Samples were tested for SOD and catalase activity (Watkins

et al., 1985). No enzyme activity was found in the hemoglobin samples. The dialyzed
Hb was frozen drop-wise in liquid N2 and stored at -70°C.

2.5

Oxyhemoglobin Preparation
Carbon monoxy Hb (HbACO and HbSCO) was oxygenated for 45 min on ice

while illuminated by a flood light. The concentration was adjusted to the required
concentrations using the absorbance at 577 nm and the extinction coefficient of 15.0
(mM/ hemeY 1 cm· 1 (Winterbourn, 1985c; La.Brake and Fung, 1992).

2.6

MetHemoglobin Preparation
HbA or HbS (160 µM) was treated with potassium ferrithiocyanate in a molar

ratio of 1 mole heme : 3 moles of potassium ferrithiocyanate. The solution was stirred
for 10 min and the excess potassium ferrithiocyanate was separated on a Sephadex G25
(Pharmacia, Piscataway, NJ) column equilibrated with 35 mM phosphate, 110 mM NaCl
pH 7.4 buffer (Perutz, 1972). This column separation allowed us to remove the excess
potassium ferrothiocyanate from metHb. The metHb fractions were pooled and the

9

concentration was determined by using the absorbance at 405 nm and its extinction
coefficient of 149 mM- 1 (Perutz, 1972).

2. 7

SUV Preparation
The BPS in CHC13 was evaporated under N2 on a rotary evaporator to remove the

CHC13 and to obtain a thin lipid film. The film was solubilized in N2 gassed phosphate
buffer or tris buffers to prepare multi lamellar vesicles (MLVs). SUVs were prepared
by sonication (LaBrake and Fung, 1992) using a VC SOT Vibra Cell™ sonicator (Sonics
& Materials Inc. Danbury, CT) and a 2 mm probe. A volume of 1 ml, of MLVs in
phosphate buffers was sonicated for 4 min at power 40 and/or 1 ml of ML Vs in tris
buffers was sonicated for 2 min at power 20. The clear solution obtained after sonication
was centrifuged at 38,000 g for 20 min to pellet large lipid vesicles and particulates
(LaBrake and Fung, 1992).

2.8

Conjugated Diene Assay
The ~onjugated diene assays (A 233 / A215 index) were performed on the lipid samples

to determine lipid peroxidation (Kim and LaBella, 1987). A sample of 10 µI of the lipid
vesicles were mixed with 1 ml of ethanol and the absorbance at 233 nm and 215 nm were
measured. The wave lengths were calibrated by using 10µ1 phosphatidylcholine in 1 ml
of absolute ethanol.

The blank phosphatidylcholine solution was made the same

concentration as the sample to be assayed in absolute ethanol. (Kim and LaBella, 1987).
Samples with an index of 0.08 are considered to be low lipid peroxidation and with 0.66
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are considered to be high index of lipid peroxidation (Szebeni and Toth, 1986). The
samples having an index above 0.2 were rejected (Szebeni and Toth, 1986; LaBrak:e and
Fung, 1992).

2. 9

Phospholipid Assay
The lipid concentrations of SUV samples were determined by the method of

Stewart (1980). A sample of 25 µl of the BPS SUV was extracted with a mixture of 1.5
ml of water, 2 ml of CHC13 and 2 ml of MeOH. The CHC13 layer was evaporated to

dryness under vacuum or N2• It was then redissolved in 2 ml of CHC13 and 2 ml of 10
N ammonium ferrothiocyanate

solution was added to obtaine a red complex.

The

mixture was vortexed for 2 min. The CHC13 layer was separated, and the absorbance
at 452 nm was obtained. The concentration of the lipid was calculated using the E of 1.9
for a 0.5 mg I ml PS solution (Stewart, 1980).

The average effective diameter of SUV s determined by quasi elastic light
scattering (QELS) particle size analyzer(Brookhaven Instruments, New Haven, CT) was
87.5

±5

nm (n = 3) for SUVs made in PllON 7.4 buffer and 88

6.8 nm (n = 3)

for SUVs made in T5K 6.5 buffer. The effective diameters of SUVs obtained from the
QELS are generally larger than what were obtained by electron microscopy (EM) (Mayer
et al., 1986). An effective diameter of - 90 nm corresponds to a 10-30 nm diameter
measured by EM (LaBrake and Fung, 1992). Thus the SUVs used in this study were
similar to those used in our earlier studies of Hb oxidation (LaBrake and Fung, 1992).
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2.10

Hemoglobin-SUV Mixtures
Hb and SUVs solutions were incubated at 37°C in phosphate buffers or at 28°C

in tris buffers of different ionic strength and were mixed to give a sample with a specific
phospholipid/Hb molar ratio. For samples with phospholipid to Hb molar ratio of 800,
240 µL of Hb (17.7 µM) and 1.0 ml of SUVs (3.4 mM BPS) were mixed to give a final
concentration of 3.4 µM for Hb and 2. 7 mM for BPS. For other phospholipid/Hb ratios
(360, 200 or 45), sample volume and Hb concentration were held constant, BPS
concentrations were varied. The phospholipid to Hb ratio of 45 was the same as that
used by Marva and Hebbel (1994).

2.11

Disappearance of OxyHemoglobin
UV-Vis absorption intensities from 500 nm to 700 nm were monitored for I h.

The oxidation of Hb was determined by using the four component (oxyHb, metHb,
hemichrome and choleglobin) analysis method (Labrake and Fung, 1992). The oxyHb,
metHb, hemichrome and choleglobin concentrations were determined by matrix equations
assay the absorbance at 577, 630, 560, and 700 nm, (Labrake and Fung, 1992;
Winterbourn, 1985c). The pseudo first order rate constant (k) for the disappearance of
oxyHb was obtained by fitting the logarithmic values of oxyHb concentration ([oxyHb]t
(%)) versus time (t) to an linear equation of In [oxyHb]t

= kt.
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2.12

Disappearance of Heme/Porphyrin
Fluorescence signals of porphyrin were used to detect heme concentration

(Schwartz et al., 1983). An oxalic acid/FeSO4 solution was used to dissociate FeH /Fe2+
from porphyrin in free heme or heme moiety in Hb.

Five microliter of Hb-SUV

mixtures were mixed well with 3 µl of Triton-X-100 and added to 1 ml of FeSO4'oxalic
acid solution (2.5 g of FeSO4 and 30.0 g of oxalic acid in 100 ml of DI water) (Schwartz
et al., 1983). The sample was heated at l00°C for 0.5 hand then cooled for 15 min at
room temperature. The fluorescence emission at 601 nm, with excitation at 405 nm, was
measured. Porphyrin concentration in the mixture was determined by using a calibration
curve made with Hb (concentration range of 0.1 µM to 30 µM) as the standard. The
porphyrin concentration was monitored as a function of time (t) in the Hb-SUV mixtures.
The decrease in the fluorescence signals was used as an indication of porphyrin
disappearance. A semi-logarithmic plot of [porphyrin] (%) versus time (t) was obtained,
and the slope from a linear regression analysis provided the first order rate constant (k)
for porphyrin disappearance in the presence of lipid vesicles.

2.13 Heme Partitioning into the Aqueous Phase
MetHb was used as the heme donor and apomyoglobin (apoMb) as the acceptor
for free heme in solution (Paul et al., 1991). MetHb concentration was adjusted to 3.4
µM per heme and the apoMb concentration to 17 µM to give a 5 molar excess of

apomyoglobin in the reaction mixture. Changes in absorbance at 409 nm were monitored
as a function of time at 25°C instead of 37°C, since absorbance changes were too fast
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to follow at 37°C. The difference in absorbance values at 409 nm between metHb (3.4
µM) and myoglobin (heme-containing myoglobin) (3.4 µM) in specific buffer was used
to represent complete heme extracted in that buffer.

2.14

Heme Transfer from Hemoglobin to SUVs
SUVs were separated from Hb in Hb-SUV mixtures by size exclusion column

chromatography. Samples were loaded immediately after mixing ( < 5 min) to a FPLC
Superose 12 (Pharmacia) column, and the elution time was about 15-20 min for SUV
fractions and about 60 min for Hb. Porphyrin and lipid concentrations were determined
on pooled SUV fractions. A hundred microliter sample from the pooled SUV fractions
in 3 µL Triton X-100 was used for porphyrin assays. Fractions of heme transferred from
Hb to SUV s were calculated as [porphyrin per mg lipid in SUV pooled
fractions]/[porphyrin per mg lipid in Hb-SUV mixture] (%). Since the heme transfer
process was faster than our separation process (we estimated it to be about 10 min or less
on our Superose column) for systems in T5K6.5 buffer, we were not able to determine
kinetic properties of heme transfer to SUVs. Therefore only the extent of heme transfer
to lipid phase was obtained.

2.15

Free Iron Concentration
Free iron concentration in samples was determined with ferrozine/neocuprion

reagent (75 mg ferrozine, 75 mg of neocproine hydrate and one drop of cone. HCl in
25.00 ml water) (Carter, 1971). Equal volumes (125µL) of sample and ascorbic acid

14

(0.02 % in 0.2 N HCI) were mixed and left at room temperature for 5 min.
Trichloroacetic acid (10 %) solution (125 µL) was then added, mixed and centrifuged at
16,000 g for 10 min to obtained a clear supernatant. Ferrozine/neocuprion reagent (25
µL) and 10 % sodium acetate (100 µL) were added to the supernatant (250 µL). The
concentration of free iron was determined by monitoring absorbance at 562 nm for the
formation of magenta colored complex of FeH with ferrozine. A calibration curve was
obtained using Fe(NH4) 2SO4 • 6H2O (104 µM to 30 µM).
Triton X-100 was added to the sample prior to the addition of assay reagents to
determine total (lipid phase plus aqueous phase) Fe ion concentrations. Aqueous phase
iron concentrations were assayed in the absence of Triton X-100. Iron concentrations
in the lipid phase were obtained by subtraction. Iron concentrations were monitored as
a function of time in Hb-SUV mixtures.

2.16

Cross-Linked Hemoglobin in the Hb-SUV mixture
Hb-SUV mixture was incubated at 37 °C. Samples were obtained every hour and

loaded to a 16 % SDS PAGE stained with Coomassie Blue. The bands on the gel were
scanned using the Logitech Scan-Man II (Logitech Inc., Fremont, CA), and the band
intensities as a function of time in each lane were analyzed with Sigma Gel soft ware
(Iandel, San Rafel, CA). The experiments was performed in Pll0N 7.4 buffer at 37 °C,
with a phospholipid/Hb molar ratio of 800, and in T5K 6.5 buffer at 28 °C, with a
phospholipid/Hb molar ratio of 360.
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2.17

Appearance of Malondialdehyde (MDA)
Thiobarbituric acid (TBA) solution was prepared by mixing TBA (0.375 mg) and

trichloroacetic acid (TCA) (10 g) in 100 ml of 0.2 N HCl solution. A sample of 50 µl
of the Hb-SUV mixture was added into 500 µl of TBA solution. The sample was boiled
for 30 min, cooled at room temperature for 15 min and centrifuged at 16,000 g for 10
min. The TBA forms a complex with the MDA giving rise to a pink colored compound.
The absorbance of the TBA-MDA complex (thiobarbituric acid reactive substances,
TBARS) formed was determined at 532 nm.

The concentration of TBARS was

determined by using a calibration curve of MDA within a concentration range of 0.10
µM to 10.00 µM (Buege and Aust, 1978). The experiments were performed in Pll0N
7.4 buffer at 37 °C and at a phospholipid/Hb molar ratio of 800.

2.18

Oxidative Products in the Hemoglobin-SUV Reaction Mixture
Hb-SUV mixture was incubated for 0, 2, and 6 h, followed by separation on a

Sepharose 4B-CL (Pharmacia, Piskataway, NJ) column (42 x 1.5 cm) equilibrated with
the experimental buffer (13.5 ml/min).

The molecular weights of the separated

components were determined using a calibration curve prepared with ribonuclease A
(13.7 kDa), carbonic anhydrase (23 kDa), ovalbumin (43 kDa), bovine serum albumin
(67 kDa), aldolase (158 kDa) and ferritin (440 kDa) as the molecular weight standards.
The experiments were performed in Pl l0N 7.4 buffer at 37 °C and at a phospholipid/Hb
molar ratio of 800 and in T5K 6.5 buffer at 28 °C and at a phospholipid/Hb molar ratio
of 3ti0.
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The separated peaks from HbA-SUV mixture at PL/Hb molar ratio of 800 were
tested for carbonyl functions using UV /Vis spectra.

2.19

Lipid Bound to the Hemoglobin
The pooled fractions separated on a Sepharose 4B-CL column as described above

were extracted with CHCl3'MeOH (1:1 v/v) mixture. The CHC13 phase was separated
and evaporated to dryness. The dried sample was redissolved in 2.0 ml CHC13 and the
lipid content was determined by the lipid assay (Stewart, 1980). Alternatively the dried
sample was redissolved in 200 µ.l CHC13 and loaded on to a high performance thin layer
chromatogram (HPTLC). The HPTLC plate was first activated with a CHCl3'MeOH (1: 1
v/v) mixture and the plate was dried for 5 hat 120 °C. The plate was then cooled for
1 h in a CaCO3 desiccator. A 20 µl sample was loaded to the plate and eluted with
CHCl3' MeOH I NH4OH (60 : 20 : 4 v/v) to half the length of the plate for high polar
components. After air drying the plate was eluted with hexane/diethyl ether/ HOAc (80

: 20 : 0.5 v/v) for the full length of the plate. The plate was visualized by spraying
the plate with 10% CuSO4 in 10 % phosphoric acid and then charring the plate at 160
°C for 10 min. The charred spots of the sample were compared with those from BPS
(Avanti Polar Lipids) and stearic acid (Sigma Chemicals).

The experiments were

performed in Pl ION 7.4 buffer at 37 °C and at a phospholipid/Hb molar ratio of 800 and
in T5K 6.5 buffer at 28 °C and at a phospholipid/Hb molar ratio of 360.

CHAPTER III
RESULTS
Previous studies have shown that the oxidation kinetics of oxyHb in Hb-SUV
mixtures depends linearly on phospholipid to Hb molar ratio (LaBrake and Fung, 1992).
The higher the molar ratio, the faster the reactions. In this study, I found that oxidation
kinetics depended on buffer conditions. I used smaller phospholipid to Hb molar ratio
values in samples with buffer conditions that provided faster kinetics and larger molar
ratios in samples with buffer conditions that provided slower kinetics. A molar ratio of
800 was used for systems in P110N7.4 buffer and molar ratios of 360, 200 and 45 for
systems in T5K6.5 buffer.

These adjustments in molar ratios positioned oxidative

reactions in Hb-SUV mixtures under different buffer conditions to similar time frame
(minutes to hours) and thus provided results under different conditions with similar
reliability.

If the molar ratio was kept the same for systems with different buffer

conditions, the oxidative reactions would span vastly different time frames (e.g. msec or
days).

3.1

Oxidative Reactions Under Physiological pH and Ionic Strength Conditions
(PllON 7.4)

3.1.1 Disappearance of OxyHb
Disappearance of Hb was determined by analyzing the UV-Vis absorption spectra.
17
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Figure L

Spectral changes from 500 - 700 nm ofHbO2

+ BPS SUVs in Pll0N 7.4

buffer as a function of time at lipid to Hb molar ratio of 800 and

37 °c.

The time interval between each spectrum was 6 min, with the bottom
spectrum taken immediately after mixing HbO2 and SUVs and the top
spectrum taken at 45 min after mixing. Characteristic absorption peaks
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Figure 2.

The semi-logarithmic plot of oxyHb concentration(%) versus time (h) for

the disappearance of Hb in the presence of BPS SUVs in Pl 1ON 7 .4 buffer
at lipid to Hb molar ratio of 800 and 37

°c. The value at each time point

was the mean value of 2 experimental runs. o HbAO2
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A typical set of spectra obtained on HbA-SUV sample and HbS-SUV sample in Pl lON
7.4 buffer as a function of time (Fig. IA & B) shows a decrease in the two characteristic
peaks for oxyHb at 577 and 565 nm, due to the disappearance of oxyHb, and an increase
in absorbance at 630 nm, due to the formation of metHb as well as a slight increase in
absorbance at 700 nm which was attributed to the formation of choleglobin and fusion
of lipid vesicles (La.Brake and Fung, 1992). A four component (oxyHb, metHb,
hemichrome and choleglobin) analysis

(LaBrake and Fung, 1992) of these spectra

allowed us to determine oxyHb concentrations as a function of time in our Hb-SUV
mixture. The semi-logarithmic plot of oxyHb concentration (%) versus time revealed a
linear relationship during the initial phase (up to about 0.5 h) for both HbA and HbS
SUV oxidation reaction mixtures (Fig. 2). Linear fitting of the first 11 data points (0 0.5 h) provided a pseudo first order rate constant for the initial disappearance of oxyHb
in the presence of SUVs. The mean rate constant of 2. 77
obtained for HbA-SUV mixture.

+

0.08 h- 1 (n

= 3) was

The time for the disappearance of 50 % of the

maximum value (tuJ of oxyHb concentration was 0.25 h. The reported rate constant
of the HbA oxidation under similar conditions was 3.20

± 0.52 h·1 (La.Brake and Fung,

1992). The mean rate constant of HbS oxidation was 2.70

+ 0.09 h·1 (n = 3) (Fig. 2)

and the t 112 for the disappearance of oxyHbS was 0.25 h . These values were very
similar to those of HbA system in PI ION 7.4 buffer.

3.1.2 Oxidative Products in Hb-SUV Mixtures in Pl10N7.4
Upon mixing (t - 5 min) of oxyHbA and SUVs in Pll0N7.4 with aphospholipid
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ratio of 800, two fractions were separated by size exclusion column (Sepharose 4B-CL)

(Fig. 3). The first fraction eluted at void volume of 23.6 ml (elution time of 1.75 h) and
was identified as SUVs.

This peak consisted of 2.4 - 2.6 mg of phospholipid, as

determined by phospholipid assays, which corresponded to about 80 - 85 % of the total
amount of BPS loaded to the column. The second fraction eluted at 65. 7 ml (elution
time of 4.8 h), corresponding to a molecular mass of 64

± 0.2 kDa (n

= 2), and was

assumed to contain mostly HbA (Fig. 3 a). Small amounts ofphospholipid (0.11

± 0.02

mg or about 4 % of total BPS) was detected by phospholipid assays. As shown earlier,
about 36 % of HbA molecules already exhibited inter-chain cross-linking, but remained
as tetramers under these conditions.
After 2 h incubation, the lipid vesicle peak (at the void volume of 23.6 ml)
became more intense, probably due to vesicle fusion induced by Hb molecules to give
extensive light scattering at 280 nm (LaBrake and Fung, 1992). This fraction consisted
about 80 - 85 % of the total amount of BPS loaded, as determined by phospholipid
assays. No fraction was collected at the 65.7 ml position. However, a fraction at 63.7
ml (elution time of 4. 7 h), corresponding to a molecular mass of 94 kDa, and a fraction
at 81.6 ml (elution time of 6.0 h), corresponding to a molecular mass of 2 kDa, were
collected (Fig. 3 b). Globin cross-linking studies discussed earlier showed about 62 %
of Hb as monomers, 26 % as dimers and 12 % as trimers, and these values were very
similar to those observed at t - 5 min. The shift in molecular mass from 64 kDa to 94
kDa was thus assumed due to an increased amount of SUV/BPS associated with Hb
molecules. The fraction with low molecular weights (2 kDa) was not analyzed but was
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Figure 3.

The elution profiles of the separation of the HbA-SUV mixture on the

sepharose 4B-Cl gel filtration column. The HbAO2 + BPS SUVs in Pl ION
7.4 buffer at a lipid to Hb molar ratio of 800 and at 37 °C were incubated
for 0, 2 and 6 h and was separated on a sepharose 4B-Cl gel filtration
column.

Elution Profiles of HbA-SUV Mixture Separated on a Sepharose 4B-Cl Column, in
Pl ION 7 .4 Buffer at 37°C
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assumed to be similar to the 79. 7 ml fraction at t

= 6 h,

as described in detail below.

After the Hb-SUV mixture was incubated for 6 h, other than the lipid peak, which
still consisted about 80 % phospholipid, a fraction at 61.2 ml (4.5 h), corresponding to
a molecular mass of 184
a molecular mass of 3

+

11 k:Da, and a fraction at 79. 7 ml (4. 7 h), corresponding to

± 0.5 k:Da (n

= 2), were detected {Fig. 3c).

The fraction at 61.2

ml (184 k:Da) exhibited no absorption peaks characteristic of the heme moiety and was
assumed to be mostly globin aggregates or choleglobin (gel electrophoresis data showed
:ii? 75 % globin cross-linking). Pacifici and coworkers, in their studies of Hb oxidation

by hydrogen peroxide, observed a peak on a Sepharose 4B column that corresponded to
120 - 180 k:Da (Pacifici et al., 1993). This fraction also consisted of small amounts of
phospholipid (0.26

±

0.02 mg, n

= 2 phospholipid or about 8 % total, as detected by

phospholipid assay). HPTLC data also indicated the presence of BPS as well as fatty
acids and aldehydes {Fig. 6, Lanes 2). The fraction at 79. 7 ml (3 k:Da) exhibited a sharp
absorbance at 265 nm that corresponded to conjugated carbonyl groups (Fig. 5). This
fraction also exhibited a trace level of BPS and fatty acids and other aldehydes, as
detected by HPTLC (Fig. 6, lane 5). Only about 1.5 % of total BPS (0.05
n

= 2)

was detected in this fraction.

+ 0.01 mg;

Thus this fraction probably consisted of low

molecular weight lipid peroxidation products.
I observed similar changes when HbS-SUV mixture that was separated on the
sepharose 4B-Cl column( Fig. 4). Initially when the Hb-SUV mixture was separated the
Hb fraction with a molecular weight of 64 k:Da and the lipid fraction eluted off with the
void volume {Fig. 4 a) . When the HbS-SUV mixture was incubated for 6 h the
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Figure 4.

The elution profiles of the separation of the HbS-SUV mixture on the
sepharose 4B-Cl gel filtration column. The HbSO2 + BPS SUVs in Pl l0N
7.4 buffer at 37 °C with a lipid to Hb molar ratio of 800 andwere
incubated for 0, 2 and 6 h and was separated on a sepharose 4B-Cl gel
filtration column.

Elution Profiles of HbS-SUV Mixture Separated on a Sepharose 4B-Cl Column, in
Pl lON 7.4 Buffer at 37°C
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Figure 5.

The UV/Vis spectrum of 3 kDa

fraction obtained from the column

separation of HbA-SUV mixture at 37

ratio of 800.

°c with phospholipid to Hb molar
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Figure 6.

The high performance thin layer chromatogram of the CHC13 extract of
the Hb fractions and the byproduct fractions separated from the size
exclusion chromatography at t

= 6 h (see Fig. 2).

The TLC was eluted

with CHCl3'MeOH/NH3OH (60:20:4) up to 50 % of the plate length and
then the plate was eluted with hexane/diethyl ether/HOAc (80:20:0.5) up
to 100 % of the plate length. The plate was visualized using 10 % CuSO4
in 10 % phosphoric acid and charring at 160 °C for 10 min.
Lane 1- BPS (Avanti Polar Lipids)
Lane 2- CHC13 extract of the 61.2 ml (184 kDa) fraction of HbA-SUVs
mixture
Lane 3- CHC13 extract of the 61.8 ml (190 kDa) fraction of HbS-SUVs
mixture
Lane 4- Stearic acid
Lane 5- CHC13 extractt of the 79. 7 ml (3 kDa) fraction of HbA-SUVs
mixture
Lane 6- CHCI3 extract of the 79. 7 ml (3 kD) fraction of HbS-SUVs
mixture
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eluted fractions we observed two new peaks appearing with molecular weights of 190
kDa and 3 kDa ( Fig. 4 c) similar to HbA-SUV mixture.

3.1.3 Globin Cross-Linking
The reaction mixture was also characterized using SDS PAGE. The Hb-SUV (t

- 5 min) exhibited bands at 15 kDa (64 % of total), 30 kDa (24 %) and a faint band at
45 kDa (12 %) of Hb (Fig. 7 A & B) for both HbA and HbS SUV mixture. Since a
native Hb gave rise to only a band at 15 kDa, under similar gel conditions the 15 kDa
band in Hb-SUV samples corresponded to those Hb molecules that were not cross-linked
and the higher molecular weight bands were due to covalently cross-linked
chains (cross-linked

a and /3

a/3 at 30 kDa, dimers and a/3a or a/3/3 at 45 kDa, trimers) (Fig. 8).

Thus at t - 5 min about 36 percent of globin were already cross-linked.

At 2 h of

incubation SDS PAGE data showed 62 % of Hb as monomers 26 % as dimers and 12
% as trimers chains. These values were similar to those obtained immediately after

mixing (t - 5 min).
I observed an increase in globin cross-linking in the Hb-SUV oxidation sample
with prolonged incubation with 43

5 h (n

= 2)

± 12

% at 3 h, 64

+6

% at 4 h and 75

±5

% _at

(Fig. 8). Similarly I observed the cross-linking of HbS in the presence of

SUV and observed 30.0 %, 27 %, 41 %, 48 %, 66 % and 70 % at - 5 min, 1 h, 2 h, 3
h, 4 h, and 5 h respectively (Fig. 8). The samples showed the appearance of bands with
a higher than 45 kDa.

These results agreed with previous findings of Hb oxidation in

the presence of H20 2 (Pacifici et al., 1993). They observed the appearance of the 32
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Figure 7.

The 16 % SDS PAGE performed on the Rb-SUV mixture in PllON 7.4
buffer at lipid to Hb molar of 800 and 37 °C, at different incubation times.
The 50 µl of the sample was loaded to the gel. A. HbA-SUV mixture, B.
HbS-SUV mixture
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SDS PAGE ofHb-SUV Mixture in PllON 7.4 Buffer
at PL/Hb = 800 & 37 °C
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Figure 8.

The % of cross-linked Hb in the Hb-SUV mixture in Pl lON 7.4 buffer at
lipid of Hb molar of 800 and 37 °Casa function of incubation time (h).
The cross-linking was monitored by performing a 16 % SOS PAGE. The
% intensity of each band was obtained by using Logitech Scan Man for

scanning and Sigma Gel analyzing software for the gel % analysis.
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kDa, and 48 kDa bands on a SDS PAGE. The t112 values for the cross-linking of Hb
was estimated to be 3.5 h for both HbA and HbS in SUVs. The cross- linked globin was
also identified as choleglobin, a species that is not well identified in the literature, but
is generally considered as denatured globin.

3.1.4 Disappearance of Heme/Porphyrin
I observed the fluorescence intensity of the porphyrin in Hb-SUV samples
decreasing with time (Fig. 9). The first order rate constant for the initial porphyrin
(heme) disappearance was 0. 76
0.11 h· 1 (n
of 0.43

+ 0.12 h·1 (n = 3) for HbA-SUV

mixture and 0. 79

±

= 3) for HbS-SUV mixture followed by a second first order rate constant

± 0.23

h· 1 (n

= 3) for HbA and 0.50 ± 0.35 h·1 for HbS.

At 0.5 h 63 % of

heme was left in the oxidation reaction mixture, and at 1.0 h it decreased to 45 % for
both HbA and HbS - SUV mixtures. The t112 value for the destruction of heme was 0. 75
h for both HbA and HbS. The results obtained for HbS-SUV mixtures were very similar
to those of HbA-SUV mixture.

3.1.5 Heme Transfer into the Lipid Phase (SUVs)
I observed only about 1 % heme transferred to the lipid phase upon mixing oxyHb
with SUVs in Pll0N :7.4 buffer for both HbA (1.10
0.07 % , n =2).

± 0.02 % , n =2) and HbS (1.15±
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Figure 9.

The semi-logarithmic plot of heme concentration ( %) versus time (h) in
Hb-BPS SUV mixture in Pl lON 7.4 buffer at lipid to Hb molar ratio of
800 and 37 °C. The heme concentration was determined by fluorescence
spectroscopy as described in the Methods section.

The fluorescence

emission of the solution was obtained at 601 nm with the excitation at 405
nm. The values presented were mean values of 3 experimental runs.
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3.1.6 Appearance of Free Iron
The free iron concentration in the Hb-SUV mixture increased as a function of
incubation time. However the semi-logarithmic plot of free iron concentrations in both
aqueous phase and lipid phase as a function of time could not be fitted with a linear
equation (Fig. 10). Therefore I was not able to describe the iron released from Hb with
a first order rate constant. The mean value of the free iron concentration was 27.4
4.9 % (n

±

= 3 ) for HbA- SUV mixture and 27.1 ± 8.0 for HbS-SUV mixture at 0.5

h, and 100 %at 10 h (Fig. 10). for both HbA and HbS-SUV mixtures. All the iron in
Hb molecules was released after 10 h incubation with SUV s.

The free iron

concentrations in HbS-SUV mixture were similar to those in HbA-SUV mixture. The
t112 values for the total iron released from HbA and HbS in the presence of SUVs were
about 1.3 h.
The concentrations of free iron in the aqueous phase increased initially and
reached a maximum value of 33.8
(Fig. 4), and 37.1

±

+ 0.0

% (n= 2) at 2.5 h for HbA -SUV mixture

0.0 % (n= 2) for HbS-SUV mixture. The concentrations in the

aqueous phase decreased after 2.5 h in HbA-SUV mixture and HbS-SUV mixture. At
10 h the mean concentration decreased to 23.1
and 16.4

±

+ 4.8

% (n= 2) for HbA-SUV mixture

1.0 % (n= 2) for HbS-SUV mixtures. The t 112 value was about 0.8 h for

both HbA and HbS.
The free iron concentrations in the lipid phase continued to increase with time for
both HbA-SUV and HbS-SUV mixtures. At t

= 2.5

present in the lipid phase in HbA-SUV sample and 28.0

h, 23.8

± 5.8

% of iron was

± 0.0 % in HbS-SUV sample.

42
Figure 10.

A. The semi-logarithmic plot of free iron concentration(%) in HbA-SUV
mixture as a function of time (h).

The iron concentrations were

determined by the foreseen assay. The iron concentration in the lipid
phase was determined by subtracting the free iron concentration in the
aqueous phase from the total free iron concentration. A.
concentration in HbA-SUV mixture
SUV mixture, and

O

t..

■

total free iron

Free iron in the lipid phase in HbA-

free iron in the aqueous phase in HbA-SUV

mixture. B. v total free iron concentration in HbS-SUV mixture •
iron in the lipid phase in HbS-SUV mixture, and
aqueous phase in HbS-SUV mixture

■

Free

free iron in the
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Free Iron Release From Hb in the Presence of BPS SUVs
In P110N 7.4 Buffer at PUHb. 800 and 37°C
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Within a period of 10 h, 76.9

± 4.8

% of free iron partitioned into the lipid phase for

HbA-SUV mixture, and 83.6

± 1.0

% for HbS-SUV mixture. The t112 values for the

iron partition into the lipid phase for both HbA and HbS was about 4.6 h. Thus after
10 h most of the iron released from Hb was partitioned into the lipid phase, with slightly
higher values for HbS-SUV mixture than for HbA-SUV mixture in Pll0N 7.4 buffer.
The results obtained for the oxidative reactions in Pll0N 7.4 buffer conditions are
summarized in Table 1.

3.1. 7 MDA Assay
The MDA assay showed a gradual increase in MDA levels in Rb-SUV system at
phospholipid to Hb molar ratio of 800 in P110N7.4 buffer (Fig. 11). Both HbA and
HbS systems exhibited similar rate of MDA formation. Initially about 0.4 µ.M MDA was
detected and this value increased to 4 µ.Mat 2.5 h. The MDA concentration leveled to
a maximum value of 6.22

±

0.01 µM {n

= 2) at

10 h for both HbA- and HbS-SUV

mixtures.

3.2

Oxidative Products Under Low pH and Low Ionic Strength Conditions (T5K 6.5
Buffer)

3.2.1 Disappearance of OxyHb
Similarly the oxidation of Hb in T5K 6.5 buffer at phospholipid to Hb molar ratio
of 360 and 4S was determined by analyzing the absorption spectra. A typical set of
spectra obtained on HbA-SUV sample and HbS-SUV sample in T5K 6.S buffer at
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Figure 11.

Formation of MDA (µM) in a Hb

+ SUV mixture as a function of time

(h). The Hb was incubated with BPS SUVs at phospholipid to Hb molar

ratio of 800 and 37 °C in PllON 7.4 buffer. The production of MDA
was determined by TBARS assay. ■ HbA + BPS SUV and □ HbS +
BPS SUV.
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Table 1.

Summary of the First Order Rate Constants and t112 Values for the

Disappearance of OxyHb, Disappearance of Heme and Appearance of Free Iron,
Appearance of MDA and Cross-Linking of Hb in PllON 7.4 Buffer at PIJHb Molar
Ratio of 800.
First Order Rate

T 1n (50 % Concentration)

Constants

(h)

HbA

HbS

HbA

HbS

Disappearance of oxyHb

2.77±0.08•

2.70±0.09

0.3

0.3

Disappearance of Heme

0.76±0.12

0.79±0.11

0.8

0.8

Total Free Fe

N/Db

N/D

1.4

1.4

Free Fe in Aqueous Phase

N/D

N/D

0.8

0.8

Free Fe in Lipid Phase

N/D

N/D

4.6

4.6

Hb Cross-Linking

N/D

N/D

3.5

3.5

MDA Formation

N/D

N/D

1.4

1.4

Appearance of Free Iron

a-

Mean value of 2-3 measurments

± the standard deviation.

b - Reaction was not first order. Thus the value was not obtained.
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phospholipid to Hb molar ratio of 360 as a function of time (Fig. 12 A & B) shows a
decrease in the two characteristic peaks for oxyHb at 577 and 565 nm and an increase
in absorbance between 600 - 700 nm. The disappearance of oxyHb in HbA- or HbSSUV mixture in T5K6.5 buffer was found to be much faster than corresponding ones in
P110N7.4 buffer at molar ratio of 800. In order to obtain reliable data, I decreased the
rate by reducing the phospholipid to Hb molar ratio to 360 and determined the first order
rate constants for the initial (up to 0.3 h) disappearance of oxyHb.

The semi-

logarithmic plot of oxyHb concentration (%) versus time revealed a linear relationship
during the initial phase (up to 0.3 h) of the reaction (Fig. 13). Linear fitting of the first
9 data point provided a pseudo first order rate constant for the initial disappearance of
oxyHb in the presence of SUVs. The mean rate constants were 0.84
for HbA, and 4.34

+

1.05 h· 1 (n

= 4) for HbS.

+ 0.1

h·1 (n

= 4)

The t112 for the initial disappearance

of oxyHbS was 0.62 h for HbA and 0.2 h for HbS. I also monitored the oxidation of
HbA and HbS at phospholipid to Hb molar ratio of 45 and obtained the rate constant of
0.1

±

0.01 h·1 (n

= 4) for HbA, and 0.16 ± 0.02 h· 1 (n = 4) for HbS (Fig.

13).

Previous studies also show that HbS has a higher oxidation rate compared to HbA
oxidation in T5K 6.5 buffer at phospholipid to Hb molar ratio of 45 in a Hb-LUV
mixture. The observed rates of 0.25
(Marva and Hebbel 1994).

± 0.02 h· 1 for HbA and 0.85 + 0.18 h· 1 for HbS

I obtained higher rate constants when buffers were not

treated with chelex-100 to remove the trace metal ions or when glassware used was not
acid washed.
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Figure 12.

+ BPS

Spectral changes from 500 - 700 nm of Hb02

SUVs in T5K 6.5

buffer as a function of time at lipid to Hb molar ratio of 360 and 28

°c.

The time intervals between each spectrum was 6 min, with the bottom
spectrum taken immediately after mixing Hb02 and SUVs and the top
spectrum taken at 45 min after mixing. Characteristic absorption peaks
for oxyHb at 577 nm and 565 nm were observed at t
prominent peak at 630 nm were observed at t

= 45 min.

BPS SUVs in T5K 6.5 buffer, and B. HbS~
buffer.

= 0,

and a

A. HbA02

+

+ BPS SUVs in T5K 6.5
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Spectral Changes in HbA and HbS
TK 6.5 Buffer, at PUHb = 360 and 28°C
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Figure 13.

The semi-logarithmic plot of oxyHb concentration(% ) versus time (h) for

the disappearance of Hb in the presence of BPS SUVs in T5K 6.5 buffer
at lipid to Hb molar ratio of 360 and 28 °C. The value at each time point
was the mean value of 4 experimental runs.
T5K 6.5 buffer, and

e
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3.2.2 Disappearance of Heme /Porphyrins
The fluorescence intensity of the porphyrin in Hb-SUV mixture, at molar ratio
of 360, in TSK6.S buffer decreased with time (Fig. 14) in a manner similar to systems
at molar ratio of 800 in P110N7.4 buffer.

Pseudo first order rate constants for

disappearance of heme at PL /Hb molar ratio of 360 were obtained by fitting the
logarithmic values of heme concentration (%) versus time (t) to a linear equation. The
rate constants that calculated were 0.63
0.93

± 0.30 h-1 (n = 6)

± 0.30 h- 1 (n = 6) for HbS-SUV mixture.

for HbA-SUV mixture and

At O.S h 43 % of heme was remaining

in HbS reaction mixture and 73 % of heme was remaining in HbA reaction mixture (Fig.
14). The t 112 value was 1.1 h for HbA and 0.7 h for HbS. I saw a very little difference
in rate constants between HbA and HbS at phospholipid to Hb ratio of 360, in TSK 6.5
buffer.
At phospholipid to Hb molar ratio of 45, the initial rate lasted for 0.7 h for both
HbA and HbS (Fig. 14). I fitted the data in this region to linear equation and only
marginal fit was obtained, as for the data with phospholipid to Hb ratio of 360. The first
order rate constants for the destruction of heme were 0.37
and 0.34

± 0.09 h·1

(n

= 4) for HbS.

± 0.16 h·1 (n = 4) for HbA

However due to the poor fit and the fact that the

error bars were large, it was difficult to determine whether results of HbA differed from
those of HbS.

3.2.3 Heme Transfer into the Lipid Phase (SUVs)
I observed a dramatic increase in the heme transfer to the lipid phase in T5K 6.5
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Figure 14.

The semi-logarithmic plot of heme concentration (%) versus time (h) in
Hb- SUV mixture in T5K 6.5 buffer at lipid to Hb molar ratio of 360
and 45 and at 28 °C.

The heme concentration was determined by

fluorescence spectroscopy. The fluorescence emission of the solution was
obtained at 601 nm with the excitation at 405 nm.

The values

presentedwere mean values of 4 experimental runs. • HbAOi + BPS SUVs
mixture in T5K 6.5 buffer,

and ■

HbS02

+ BPS SUVs mixture in T5K

6.5 buffer at phospholipid to Hb molar ratio of 45 and O HbAOi
SUVs in T5K 6.5 buffer and □ HbSOi

+ BPS

+ BPS SUVs in T5K 6.5 buffer

at phospholipid to Hb molar ratio of 360.
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Figure 15.

The semi-logarithmic plot of free iron concentration (%) in Hb-SUV
mixture as a function of time (h) in T5K 6.5 buffer at pbospbolipid to Hb
molar ratio of 360 and incubated at 28 °C. The iron concentrations were
determined by the foreseen assay.
mixture

□

HbA-SUV mixture, o HbS-SUV

Free Iron Release From Hemoglobin in the PResence of BPS SUVs
In T5K 6.5 buffer at PI/Hb = 360 and 28°C
100-.------------------------.

.a

:c
E

,,at

:
II

.,

.!!

--

10

~

~
C

_g

.,

-□-HbA

.t

-0-HbS

3

0

Time (h)

4

58
1 % observed in PllON 7.4 buffer, 22.5

buffer. Instead of transferred rapidly (t
and 94.3

±

>

±

0.7 % of heme

10 min) to the lipid phase upon mixing Hb and SUVs fot HbA

4.9 % for HbS.

3.2.4 Appearance of Free Iron
As for systems in P110N7.4 buffer, I was not able to fit the semi-logarithmic plot
of free iron concentrations in T5K6.5 buffer as a function of time with a linear equation.
Total free iron concentration increased as a function of time (Fig.15) in a manner similar
to systems in P110N7.4 buffer. After 4 h incubation, 67. 7
as free iron in HbA system and 71.6

±

+

1.0 % iron were found

2.0 % in HbS system. The t 112 values for the

iron released from Hb in the presence of SUVs were 2.3 h for HbS and 1.5 h for HbA.
The iron concentration in the lipid or aqueous phase were not determined for these
systems in T5K 6.5 buffer.
The results obtained for the oxidative reactions in T5K 6.5 buffer conditions are
summariz.ed in Table 2.

3.2.5 Globin Cross-Linking
I also characterized the components in the oxidation reaction mixture by gel
electrophoresis to detect Hb chains and cross-linked products in Hb-SUV mixture in T5K
6.5 buffer at a phospholipid to Hb molar ratio of 360. The HbA- and HbS-SUV samples
both showed bands at 15 kDa, 30 kDa and a faint band at 45 kDa soon after mixing (t

- 5 min ) (Fig. 16 A & B). At t - 5 min I observed about 36 % of covalently cross-

59

Table 2.

Summary of the First Order Rate Constants and t 112 Values for the

Disappearance of OxyHb, Disappearance of Heme and Appearance of Free Iron and
Cross-Linking of Hb in TSK 6.S Buffer at PIJHb Molar Ratio of 360.
First Order Rate

t112 (SO % Concentration)

(h•l)

Constants

{h)

HbA

HbS

HbA

HbS

Disappearance of oxyHb

0.84±0.10-

4.34±1.05

0.6

0.2

Disappearance of Heme

0.63±0.30

0.93±0.30

1.1

0.7

Total Free Iron Released

N/Db

N/D

1.4

2.2

Hb Cross-Linking

N/D

N/D

1.4

0.3

a-

Mean value of 2-3 measurments

+ the standard deviation.

b - Reaction was not first order. Thus the value was not obtained.
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Figure 16.

The 16 % SDS PAGE performed on the Hb-SUV mixture in TSK 6.S
buffer at lipid to Hb molar of 360 and 28

°c, at different incubation times.

The 50 µ.l of the sample was loaded to the gel. A. HbA-SUV mixture,
B. HbS-SUV mixture

SDS PAGE ofHb-SUV Mixture in T5K 6.5 Buffer
at PL/Hb = 360 and 28 °C
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Figure 17.

The % of cross-linked Hb in the Hb-SUV mixture in TSK 6.5 buffer at
lipid to Hb molar of 360 and 28

°c as a function

of incubation time (h).

The cross-linking was monitored by performing a 16 % SDS PAGE. The
% intensity of each band was obtained by using Logitech Scan Man for

scanning and Sigma Gel analyzing software for the gel % analysis.

■

HbA-SUV mixture and o HbS-SUV mixture as a function of incubation
time (h).

Cross-Linking of Hemoglobin in the Presence of BPS SUVs
In T6K 6.6 Buffer at PUHb a 360 and 28°C
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linked Hb in the HbA-SUV mixture and 47 % in HbS-SUV mixture (Fig. 17). After
prolonged incubation of the HbA-SUV mixture, cross-linking increased to 41.61 % at
1 h, 63 % at 2 h, 70 % at 3 h, 71 % at 4 h and the cross-linking reached a plateau
value of - 75 % at 5 h. The cross-linking of HbS appeared to be slightly faster with
about 60 % at 1 h, , 73 % at 2 h, and 81 % fort

= 3 -5 h.

The t112 value for the

cross-linking of Hb 0.25 h for the HbS-SUV mixture and 1.4 h for the HbA-SUV
mixture, showing a difference between HbA and HbS in covalently cross-linking between
their subunits.

3.3

Globin-Heme Affinity
I used apomyoglobin (apoMb) to extract heme from metHb to measure the heme

and globin affinity in both HbA and HbS molecules under both Pl 10N7.4 and T5K6.5
buffer conditions. The heme extraction profiles as a function of time in both P110N7.4
and T5K6.5 buffers at 25°C were similar (Fig. 18 and Fig.19 respectively). A fast
phase kinetic followed by a slow phase kinetic was observed. These results were
qualitatively similar to those published with an initial fast phase kinetics, which was
attributed to heme extraction from ~-chains, followed by a slower phase which attributed
to heme extraction from a-chains (Benesch and Kwong, 1990). I used the time for 25

percent of the heme to be transferred to apoMb (Benesch and Kwong, 1990) to represent
rates of the heme transfer. The time taken for 25 % of the heme to be transferred from
metHbA to apoMb in Pll0N 7.4 buffer was 1.7
was 1.6

± 0.2 h (n = 3) and that for metHbS

± 0.1 h (n = 3) (Fig. 18). The heme release from Hb in the T5K 6.5 buffer
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Figure 18.

The heme partitioning into apomyoglobin from metHb as a function of

time in PllON 7.4 buffer. MetHb and apoMb was mixed in a 1: 5 molar ratio and was
incubated at 25 ° C.

An increase in absorbance at 409 nm was monitotred as an

indication of heme being coordinated to apoMb. Heme containing Mb at the same
concentration as metHb was used to give absorbance reading for 100 % heme transfer.
The ratio of absorbance difference for apoMb and Mb (%) were used to represent heme
transferred from Hb to apoMb.
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Figure 19.

The heme partitioning into apomyoglobin from metHb as a function of
time in T5K 6.5 buffer. MetHb and apoMb was mixed in a 1: 5 molar
ratio and was incubated at 25 ° C. An increase in absorbance at 409 nm
was monitotred as an indication of heme being coordinated to apoMb.
Heme containing Mb at the same concentration as metHb was used to give
absorbance reading for 100 % heme transfer. The ratio of absorbance
difference for apoMb and Mb (%) were used to represent heme transferred
from Hb to apoMb.
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Figure 20.

Heme partitioning into the lipid phase as a function of ionic strength and
osmolarity. The Hb in Hb

+ BPS SUV mixture in the experimental buffer

was mixed with SUV to Hb molar ratio of 360, and 200 was immediately
separated on a superose 12 FPLC column. The lipid fraction was collected,
and the heme concentration in he lipid phase was determined. Values were
presented as a percentage of heme partitioned into the lipid phase.
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was 3.2

+ 0.2 h (n = 2) for metHbS and 3.8 ± 0.0 h (n = 2) for metHbA (Fig. 19).

I observed that at low pH and low ionic strength conditions less heme transferred to
apoMb compared to that of in high pH and higher ionic strength. A small difference
between HbA and HbS was observed in T5K 6.5 buffer. These results are similar to the
previously reported values of heme transfer under low pH which are due to the decrease
in the affinity between free heme and apoMb at low pH (Benesch and Kwong, 1990).

3.4

Ionic Strength and pH Effects on Heme Transfer in Hb-SUV Systems
Since the heme transfer from Hb to lipid phase in P110N7.4 buffer was found to

be very different from that in T5K6.5 buffer for both HbA and HbS -SUV systems, I
also studied the heme transfer as a function of ionic strength and pH in both phosphate
and tris buffer systems. Since phosphate buffers were prepared with 35 mM phosphate,
whereas tris buffers were prepared with 10 mM tris, osmolarities rather than salt
concentrations were used to show ionic strength effects on heme concentrations in the
lipid phase. As shown in Fig. 20 and Fig. 21, a strong osmolarity dependent was
observed for the HbS system in tris buffers. In addition, a large difference in heme
concentrations in lipid phase was observed between HbA and HbS systems at low
osmolarities. Replacement of KCl with NaCl did not affect the heme concentrations in
the lipid phase. For HbS systems, 97
phase in T5K6.5 buffer and 100
systems, 26
0 % (n

+ 7 % (n = 2) of heme were found in the lipid

± 0 % (n = 2) in T5N6.5 buffer (Fig. 20).

For HbA

± 5 % (n = 4) heme was released from Hb in T5K6.5 buffer and 29 ±

= 2) in T5N6.5 buffer.

I observed little difference between the results obtained
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for T5K 6.5 buffer systems and in T5N 6.5 buffer systems. This indicated that the use
of KCl or NaCl did not affect the amount of the heme release. In T20K 6.5 buffer, I
observed 50

± 5

mixture and 20
% (n

% (n =3) heme was transferred to the lipid phase for HbS-SUV

+ 1 % (n =2) for the HbA-SUV system. In T85K 6.5 buffer, 21 ± 1

= 2) of heme was transferred into the lipid phase for HbS system and 11 ± 2 %

(n = 2) for HbA-SUV system. I observed, with the increase of the ionic strength, the
extent of heme transfer decreased and the differences between heme transferred in HbA
and HbS system decreased.
The concentrations of heme in the lipid phase decreased as pH increased. For
HbS systems, at pH 6.5, 28

±6

% (n

in P10N6.5 buffer, but at pH 7.4 only 3

= 3) of the heme were found in the lipid phase
+0

(Fig. 21). For HbA system, at pH 6.5, 16

% (n = 3) were found in P10N7.4 buffer

+3

% (n = 3) heme were found in the lipid

phase in P10N6.5 buffer, but at pH 7.4 only 3

±

1 % (n

= 2) in Pl0N7.4 buffer.

Thus in phosphate buffer with 10 mM NaCl, a difference in heme concentrations in lipid
phase was observed at pH 6.5 between HbA and HbS systems, but not at pH 7.4. Under
physiological ionic strength and pH, very little heme was found in the lipid phase in both
the HbA and HbS systems. In P0N6.5 buffer 24
into the lipid phase for HbS system and 10
P50K 6.5 buffer 9.02
and 11

±

+

±2

% (n

3 % (n

= 3) heme was transferred

= 3) for

the HbA system. In

± 1 % (n = 3) heme was transferred into the lipid phase for HbS

1 % for HbA system. Similarly, in phosphate buffers I observed that the

extent of heme transfer decreases with the increase of ionic strength.

At low ionic

strength phosphate buffers (PON6.5 and P10N6.5) I observed differences between the
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Figure 21.

Heme partitioning into the lipid phase as a function of ionic strength and
osmolarity. The Hb in Hb

+ BPS SUV mixture in the experimental buffer

was mixed with SUV to Hb molar ratio of 800, and 200 and was
immediately separated on a Superose 12 FPLC column. The lipid fraction
was collected, and the heme concentration in the

lipid phase was

determined. The values were presented as a percentage of heme from the
initial heme in the reaction mixture.
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HbS and HbA systems. As the ionic strength and/or pH was increased (PSON6.S and
PlON7.4) the HbA and HbS systems exhibited similar values for the heme transfer. The
results are summariz.ed in Table 3.
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Table 3. Heme(%) Transfer into BPS SUVs Under Different Buffer Conditions
Buffer
PON 6.5
Pl0N 6.5

P50N 6.5

Pl0N 7.4
Pll0N 7.4

T5K 6.5
T5K 6.5

T5N 6.5

120K 6.5

T85K 6.5

PU

Osmolarity
(mmoles/kg)

Hb

70

200

90
130

90
240

70

70
70

90

130

200

200

200
800

360
200
200

200

200

Hb

n"

% Heme

%Heme(IN/
%Heme(HbA>

HbA

3

10.2+3.2·

2.4

HbS

3

24.3±2.1

HbA

3

15.6±3.8

HbS

3

26.7±4.6

HbA

3

10.0±1.0

HbS

3

10.7±0.6

HbA

2

6.0± 0.0

HbS

3

6.0+1.0

HbA

2

1.0±0.0

HbS

2

1.0±0.0

HbA

3

22.5±0.7

HbS

3

94.3±4.9

HbA

2

28.3±2.2

HbS

4

97.4±4.6

HbA

2

28.5±0.1

HbS

2

100±0.0

HbA

2

20.0±1.4

HbS

3

50.3±5.1

HbA

2

10.5±2.1

HbS

2

20.5±0.7

a- Mean value of 2-3 measurments ± the standard deviation
b- Number of individual runs

1.7

1.1

1.0
1.0

4.2
3.4

3.5

2.5

2.0

CHAPTER IV
DISCUSSION

Oxidation of oxyHb in aqueous solution is complex and involves many
intermediate species, including metHb, hemichrome, choleglobin, superoxide anion,
hydrogen peroxide, hydroxyl radical, etc. (Winterbourn, 1990b; Winterbourn 1985b).
And some of these intermediate species include a subset of compounds. For example,
hemichrome is a general classification of many different compounds (Peisach and
Blumberg, 1975) and choleglobin is often not well defined (Winterbourn, 1990b; Pacifici
et al., 1993). Oxidation of oxyHb in the presence of lipid surface is further complicated
not only by additional intermediate species from lipid molecules but also by reactions in
the aqueous phase and in the lipid phase. The presence of a lipid phase also promotes
the disappearance of oxyHb (LaBrake and Fung, 1993) and the accumulation of
hydrophobic species such as heme and porphyrin in the lipid phase. In this study, we
systematically monitored the disappearance of oxyHb and the formation of three
intermediate species in oxyHb and SUV mixtures to further our understanding of the
oxidative reactions of oxyHb in the presence of lipid surface under different buffer
conditions. These three intermediates were heme/porphyrin, free iron ion and MDA.
The iron concentration in both the lipid and aqueous phase was monitored.
My results support the earlier finding that lipid surface enhances oxyHb
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disappearance and metHb formation. In a system consisting of simply oxyHb and lipid
molecules (with no or little initial Hb oxidation and lipid peroxidation products) the lipid
surface enhances the oxidation of oxyHb. When the oxyHb-SUV mixture was incubated
in physiological buffer (Pll0N 7.4) the disappearance of oxyHbA was observed
immediately after mixing, with a pseudo first order rate constant of 2.8 h·1• I also
observed the Hb undergoing cross-linking immediately after mixing (30 % cross-linked
Hb products at - 5 min). Subsequent to the disappearance of oxyHbA, I observed the
disappearance of heme, with a first order rate constant of 0.8 h·1, and the appearance of
free iron. The data on the appearance of iron could not be fitted to first order reaction
kinetics. At 0.3 h about half of the oxyHb was disappeared and, at 0.8 h about half of
the heme was disappeared and at about 1.3 h 50 % of the heme iron was detected as free
iron (iron free from Hb).
The oxygen radicals (02) formed during the process of the Hb oxidation were
more likely to react at its generation site.

Therefor the decrease in the heme

concentration that I detected was probably due to the presence of these oxygen radical,
since reactions between heme and oxygen radicals lead to the destruction of the porphyrin
(Cantoni et al., 1981). The first step of the destruction of porphyrin would be the
cleavage of the methylene bridge of the porphyrin ring carbon which leads to the
formation of biliverdin. Since biliverdin undergoes further oxidation, resulting in the
formation of smaller fragments (Brown and Jones, 1968), I did not detect any biliverdin
in our reaction mixture. The destruction of heme caused the release of free iron from
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Hb.
One of the most interesting findings was the distribution of the iron released from
Hb molecules. As expected iron concentrations in Hb-SUV mixtures increased as a
function of time. However,iron concentrations in the aqueous phase reached a maximum
value of 30 - 40 % at about 2.5 h before decreasing to only about 24 % at 10 h. Initially
the iron concentrations in the lipid phase increased with slightly slower rates than that
in the aqueous phase, but the concentration continued to increase after 2.5 hand reached
almost 100 % at 10 h. The t112 value for total Fe release was found to be 1.3 h.
As a consequence of the accumulation of iron ions in the lipid phase, lipid
peroxidation became significant. MDA concentration increased rapidly and exhibited a
10 fold increase (4µM) at 2.5 h.

At the end of 10 h, about 6 µM of MDA was

detected. It was interesting to see that the t112 of the MDA formation was 1.4 h, a value
very similar to that of iron release.
At t

= 2 h when about 30 % of iron were found in the lipid phase,

substantial

amount of lipid was degraded. A
fraction with molecular masses much smaller than Hb (2-3 kDa) was separated from
other oxidative components.

This fraction exhibited a sharp absorption at 265 nm

suggesting the presence of conjugated carbonyl groups.
The initial cross-linking of globin chains was much faster than the appearance of
iron. Immediately after mixing of oxyHb with SUVs, about 36 % of globin already
appeared to be crossed-linked (mostly between chains within the Hb tetra.mer such that
the molecular mass remained as 64 kDa). During this time interval, disappearance of
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oxyHb was detected. Thus the cross-linking of globin chains was probably due to the
generation of oxygen radicals but not necessarily in the presence of iron.

Previous

studies show that the reaction of Hb with H2O2 lead to the formation of ferryl-Hb {Fe4 +).
The Fe4 + in ferryl-Hb can undergo electron transfer with neighboring amino acid tyrosine
42 forming a radical on the tyrosine 42 residue (McArthur and Davies, 1993). This
radical may initiate the formation of radicals on other tyrosine residues in globin subunits
leading to the formation of a bi-tyrosine cross-link and the association of subunits in the
Hb molecule (Giulivi et al., 1994; Pacifici et al., 1993).

It is interesting to compare the results from HbA with those from HbS since HbS
has been considered to exhibit faster oxidation rates that lead to membrane abnormalities
(Hebble, 1986; Marva and Hebbel, 1994). However I found little difference between
HbA and HbS in buffers under physiological conditions (P 11 0N7. 4) in the disappearance
of oxyHb, Hb cross-linking, heme destruction, Fe release MDA formation and heme
release into the lipid phase. All the t1n values and the rate constant obtained for HbS
were found to be very similar to those of HbA.
Under low salt and low pH conditions (T5K6.5), the disappearance of oxyHb was
considerably faster than in high salt, high pH buffer condition. Since the oxidation
reaction under low salt low pH buffer condition was fast, we reduced the phospholipid
to Hb molar ratio from 800 to 360 to slow down the reaction to monitor and compare
the kinetics between HbS and HbA reliably. The oxidation rate constants were 4.34 h·1
for HbS and 0.84 h· 1 for HbA, showing a 5.2 times increase in HbS system. We also
observed a difference in the cross-linking of Hb subunits in HbA and HbS systems.
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The destruction of heme in the presence of SUVs did not show much difference
between the two Hbs. Since the destruction of Hb led to the release of free iron, we also
did not see differences in the release of total free iron. We believe that the destruction
of heme could proceed when heme is in either the aqueous phase or the lipid phase.
The heme transfer into SUV from HbS and HbA showed no difference in Pll0N
7.4 buffer but showed a drastic difference in T5K 6.5 buffer. The heme transfer from
HbS was 10 times greater in HbS-SUV system than from HbA in HbA-SUV system in
T5K 6.5 buffer. The difference could not be explained by the globin-heme affinity in
HbS in T5K6.5, since we found that both HbA and HbS exhibited similar heme-globin
affinity in both P110N7.4 and T5K6.5 buffers, as determined by apomyoglobin-heme
extraction. At lower pH (T5K 6.5), we observed that less heme (30 %) was extracted
by apoMb as compared to 50 % in high salt high pH buffer conditions (Pll0N 7.4).
This is probably due to reduced affinity of heme towards apoMb at low pH (Benesch and
Kwong, 1990).
Heme partitioning into the lipid phase may be represented by two steps. First,
heme release from the globin to the aqueous phase, and then the free heme is transferred
to a heme acceptor (Smith et al., 1984). The heme transfer from Hb is biphasic. The
fast phase is the release of heme from

/3

chains and slow phase represents the release

from<¥ chains (Paul et al., 1991). The Fe2+- proximal histidine covalent bond in oxyHb
prevents the heme loss from globin (Whitaker et al., 1995) and also histidine 64, valine
68 and porphyrin interactions inhibit the release of heme (Hargrove et al., 1994). My
results showed that heme from Hb partitioning into apoMb was a rather a slow process
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under both physiological and non-physiological buffer conditions. In 150 mM phosphate
buffer at pH 7.0 a complete release of heme occurs within 3 -4 days (Hargrove.et al.,
1994). Due to the protonation of the proximal histidine under low pH conditions the
release of heme is much faster than at physiological pH (Hargrove et al., 1994). I did
not see much difference in the rate of heme release between HbA and HbS in P110N 7.4
buffer or in T5K 6.5 buffer Qow salt and low pH); although we observed a large
difference in the heme transfer into the lipid phase between HbA and HbS in T5K 6.5
buffer.
It has been found that CO-heme partitions between the external solvent phase and

the outer lipid layer of the membrane at a rapid rate (rate constant of about 7 x

HP M·1

s·1). The rate limiting steps of this reaction are the separation of heme from the globin
and the solvation of the heme in the aqueous phase (Smith et al., 1991). Since I did not
see much difference in the heme release into the aqueous phase under both buffer
conditions we believe that the rate for the heme-proximal histidine bond breaking and the
heme solvation in the aqueous phase to be the same for both HbA and HbS. I observed
a difference in the acceptance of the heme by the SUV at low salt and low pH buffer
conditions. It appearers that the ionic strength affects the heme transfer into the lipid
phase. I observed that the release of heme into the lipid phase drastically decreased as
the KCl concentration (osmolarity) was increased in tris buffers. Similarly when the
osmolarity of the phosphate buffers were increased I observed a decreased in the heme
transfer as well as a decrease in the differences between HbA and HbS.

It is also interesting to discuss the effects of tris and the phosphate buffers. I
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clearly showed that tris buffers have a greater effect on heme transfer as compared to
phosphate buffers. Previous investigations showed that tris buffers could cause many
adverse effects on the proteins (Bubb et al., 1995; Gillespie and McKnight, 1976). They
showed that tris(2-amino-2-hydroxymethylpropane-1-3-diol), can react with proteins and
small molecules as aldehydes. Pinder and co workers ( 1995) showed the use of tris
solutions as a denaturating agent similar to guanidinium chloride, for depolymeriz.atiion
of proteins. The capability of tris to form complexes with a wide range of metal ions
(group IlA metals and transition metals) (Scheller et al., 1980) may produce adverse
effects on Hb oxidation. Since the presence of metal ions have shown to enhance the
oxidation of Hb (Winterboum and Carrell, 1977)
Differences between HbA and HbS in oxidative reactions (disappearance of
oxyHb, Hb cross-linking and heme transfer into SUVs) were mostly at low salt and low
pH conditions.

The heme transfer experiments performed at different osmolarities

showed that an increase in the Cl" concentration decreased the.heme transfer into the lipid
phase. This is probably due to a stabilizing effect of the CI· ions on the globin structure.
Previous studies have shown that the denaturation of myoglobin occur much faster under
low salt (Cl") and low pH conditions (Loh et al., 1995). Since Mb and Hb have similar
structural characteristics one can assume that the CI· effects on Hb structure are similar
to those on Mb structure. The c1· stabilizes the helical structure of the proteins and at
low c1· concentration B, C, E and H helices are unfolded (Loh et al., 1995). Unfolding
the E helix changes the conformation of the distal histidine (F8 -histidine) and causes
the exposure of the heme to the aqueous environment, leading to an increase Fe2+
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oxidation and the release of heme. Oxidation of Hb leads to conformational changes in
F and E helices (Dong et. al. 1995). Whitaker et al. (1995) showed that in the absence
of the D helix in Mb the mobility of C- and E-helices increased and the rate of hemin
loss increased by 50-fold. These helices (E and F) carry the proximal histidine (F8) and
the distal histidine (E7). The orientation of these histidine residues are very important
in the retention of heme at the heme pocket (Hargrove et al., 1994). Oxidation Fe2+ to
pe3+ in Hb weakens the proximal histidine-Fe bond and releases the heme from the
oxidized Hb. Protonation of the histidine residues under low pH also makes the release
of heme easier.

HbS molecule exhibits a higher surface activity and more surface

hydrophobicity than HbA (Hirsch et al., 1980). It is also shown that HbS has a greater
affinity towards the membrane compared to HbA (Fung et al., 1975). These studies
showed that under low pH and low salt conditions (5 mM phosphate at pH 6.0) HbS had
a greater affinity towards the membrane and upon addition of Ct, under high salt high
pH (physiological) conditions HbS had a lower affinity towards membrane. Since HbS
interacts with SUV to a greater extent compared to HbA especially at low salt and low
pH buffer conditions it is possible for the HbS as compared to HbA, to have a higher
rate of oxidation and a higher reactivity towards SUVs.
Results also show that SUVs act as a better heme acceptor than aJX>Mb. It has
been suggested that the carboxylic side chains and the Fe3 + atom in the porphyrin (heme)
occupies site close to phospholipid head groups when partitioned into the lipid bilayer
(Kurelova and Brault, 1994; Tipping et al., 1979) and the dimethyl-divinyl "end" of the
heme is immersed into the hydrocarbon region (Tipping et al., 1979).
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I saw very little differences between HbA and HbS-systems that the disappearance
of heme and in the release of total free iron. Since I argue that the iron is the major
little differences in the lipid peroxidation in these two systems are expected even at low
ionic strengths.
HbS has a mutation at the (j6 position. ~6 glutamic acid is substituted by valine.
The most prominent feature of the HbS is the polymerization of deoxyHbS. Crystal
structure did not show differences between oxyHbA and oxyHbS. NMR studies showed
some irregulations on some surface residues in HbS in both oxy and deoxy states, but no
structural differences at the heme pocket was observed (Fung et al., 197S). Fronticelli
(1978) showed differences between the CD spectra of HbA and HbS at the soret region
which were believed to be due to the changes in the~ globin chain. It is also found that
the ~ globin chains of HbA has a higher affinity to the a globin chains than the

~

globin

chains of HbS, giving HbA a higher tetra.mer stability than HbS (Shaeffer, 1980). It is
believed that the abnormalities observed in the sickle cell membrane is due to the faster
rate of oxidation in HbS (Hebbel, 1986). My experiments show that under physiological
conditions HbS does not undergo higher rate of oxidation to give membrane
abnormalities. However faster disappearance of oxyHb in HbS was observed at pH and
low ionic strength. Differences were also observed on Hb cross-linking and heme release
from Hb into SUVs. When the sickle RBCs undergo some cellular change to cause the
pH and the ionic strength to be lowered, faster oxidation in HbS are expected. This
increase in the oxidation of HbS could lead to the higher level of Hb cross-linking and
heme release from Hb. However little difference in the heme destruction and in the free

86
iron release from Hb even under low pH and low ionic strength was observed between
HbA and HbS. Thus it is possible that the abnormalities in sickle erythrocyte membranes
are due to the Hb denaturation (Hb cross-linking) leading to the buildup of hemichrome
in the RBC membrane and not due to abnormal lipid peroxidation.
Results obtained from these studies also provide insight towards the development
of blood substitute using liposome encapsulated Hb. Research efforts on blood substitute
have mainly focused on oxygen binding capacity and stability of Hb at low temperatures
(Tsuchida, 1994). An important factor to consider is the release of free iron from Hb
which may cause many toxic effects on the endothelial cell. I believe it is also important
to avoid non-physiological buffers such as tris since these buffers may initiate destructive
reactions in the Hb-liposome systems.
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